Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,728.50
Bid: 1,727.00
Ask: 1,728.00
Change: 23.50 (1.38%)
Spread: 1.00 (0.058%)
Open: 1,705.00
High: 1,729.50
Low: 1,695.50
Prev. Close: 1,705.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-UK bluechips give up gains as sterling strengthens

Mon, 09th Sep 2019 09:52

* FTSE 100 down 0.6%, FTSE 250 down 0.1%

* Multinationals drop as pound gains

* ABF falls after weak trading update

* Shopping centre operator Intu jumps on deal report
(Adds company news items, updates share moves)

By Muvija M and Indranil Sarkar

Sept 9 (Reuters) - London's FTSE 100 fell on Monday as the
pound ploughed ahead after unexpectedly robust economic data and
as no-deal Brexit worries tempered, leaving
internationally-focussed stocks in the dumps.

The blue-chip index lost 0.6%, shedding earlier
gains and lagging its European peers, due to steep falls in
pharmaceutical shares AstraZeneca, GlaxoSmithKline
, and consumer goods giant Unilever.

The FTSE 250 index dipped 0.1%, though losses were
limited thanks to a 10.4% surge in Intu Properties
after the Times reported that private equity firm Orion Capital
Managers was looking to buy the shopping centre operator.

Sterling scaled a six-week high as fears of a recession were
kept in check after data showed Britain's economy picked up more
than expected in July despite Brexit uncertainty.

However, the local currency handed back some of those gains
after news that John Bercow, Speaker in Britain's House of
Commons, would be standing down from the role.

Over three years after Britain voted to leave the European
Union, matters have only gotten more complicated as the process
plays out.

In the latest twist, parliament passed a bill demanding that
Prime Minister Boris Johnson delay Brexit unless he strikes a
new deal, while his office insisted that Brexit would happen on
Oct. 31, "no ifs and buts".

A NO DEAL OR A NEW REFERENDUM

"An unsettled UK political and economic landscape could be
with us for some time," BlackRock analysts wrote in their weekly
note.

"Six months ago, a negotiated deal looked most likely; now,
the then-extreme outcomes – no-deal or a new referendum – look
to have become more plausible."

Helping contain losses on the main bourse were oil majors
Shell and BP, both of which eked out near 1%
gains on hopes that Saudi Arabia's new energy minister will
continue to support output cuts.

Elsewhere, Wall Street indexes gained on growing hopes that
central banks will step in with stimulus plans after a data
showed an unexpected fall in China's exports last month, while
another one pointed to a slowdown in Japan's economy in the
second quarter.

The weakness reflected an impact from the prolonged
Sino-U.S. trade war to global economic growth.

The dispute saw a sharp escalation last month when the
United States announced higher tariffs on Chinese goods. That
had dragged the FTSE 100 to its biggest monthly fall so far this
year that month.

On Monday, the index saw some news-related falls, with
Associated British Foods losing 2.1% after poor outlook
for its Primark fashion chain and British Airways owner IAG
dropping 1.5% as it cancelled nearly all its flights
due to strikes.
(Reporting by Indranil Sarkar in Bengaluru; editing by Arun
Koyyur and Toby Chopra)

More News
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.